QUOTED. 12 December 2019. Scott Whitaker
US congressional leaders and medtech industry advocacy group AdvaMed are giving their full-throated endorsement to a US-Mexico-Canada (USMCA) trade agreement announced by the US Trade Representative's Office on 10 December. See what AdvaMed's president and CEO, Scott Whitaker, said about it in a statement here.
“The USMCA represents a significant step forward in terms of transparency, regulatory fairness and ensuring open access to markets across the three countries." – Scott Whitaker, president and CEO, AdvaMedClick here for a free trial of Medtech Insight